A detailed history of California State Teachers Retirement System transactions in Immunovant, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 48,909 shares of IMVT stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,909
Previous 50,235 2.64%
Holding current value
$1.35 Million
Previous $1.33 Million 1.43%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.51 - $27.51 $36,478 - $36,478
-1,326 Reduced 2.64%
48,909 $1.35 Million
Q2 2024

Aug 14, 2024

SELL
$25.1 - $31.61 $18,172 - $22,885
-724 Reduced 1.42%
50,235 $1.33 Million
Q1 2024

May 15, 2024

SELL
$30.27 - $43.79 $88,872 - $128,567
-2,936 Reduced 5.45%
50,959 $1.65 Million
Q4 2023

Feb 13, 2024

SELL
$31.31 - $44.19 $313,976 - $443,137
-10,028 Reduced 15.69%
53,895 $2.27 Million
Q3 2023

Nov 14, 2023

BUY
$18.55 - $39.96 $2,430 - $5,234
131 Added 0.21%
63,923 $2.45 Million
Q2 2023

Aug 21, 2023

BUY
$14.2 - $23.75 $187,724 - $313,975
13,220 Added 26.14%
63,792 $1.21 Million
Q1 2023

May 09, 2023

SELL
$15.27 - $19.72 $12,261 - $15,835
-803 Reduced 1.56%
50,572 $784,000
Q4 2022

Feb 14, 2023

BUY
$6.59 - $17.75 $3,374 - $9,088
512 Added 1.01%
51,375 $911,000
Q3 2022

Nov 18, 2022

BUY
$3.93 - $6.37 $27 - $44
7 Added 0.01%
50,863 $284,000
Q2 2022

Aug 15, 2022

SELL
$3.38 - $5.65 $1,990 - $3,327
-589 Reduced 1.14%
50,856 $198,000
Q1 2022

May 16, 2022

SELL
$5.06 - $8.77 $19,683 - $34,115
-3,890 Reduced 7.03%
51,445 $283,000
Q4 2021

Feb 15, 2022

BUY
$7.33 - $9.32 $36,202 - $46,031
4,939 Added 9.8%
55,335 $471,000
Q3 2021

Nov 15, 2021

SELL
$7.01 - $11.37 $9,105 - $14,769
-1,299 Reduced 2.51%
50,396 $438,000
Q2 2021

Aug 16, 2021

SELL
$9.4 - $16.85 $45,543 - $81,638
-4,845 Reduced 8.57%
51,695 $546,000
Q1 2021

May 18, 2021

SELL
$13.08 - $49.6 $4,905 - $18,600
-375 Reduced 0.66%
56,540 $907,000
Q4 2020

Feb 16, 2021

BUY
$36.36 - $52.71 $148,457 - $215,214
4,083 Added 7.73%
56,915 $2.63 Million
Q3 2020

Nov 17, 2020

BUY
$22.61 - $38.9 $543,046 - $934,300
24,018 Added 83.36%
52,832 $1.86 Million
Q2 2020

Aug 17, 2020

BUY
$13.87 - $28.44 $399,650 - $819,470
28,814 New
28,814 $702,000

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.